Navigation Links
Angiotech Enters License, Distribution and Supply Agreements for Fibrin and Thrombin Technologies with Haemacure Corporation
Date:6/3/2009

Angiotech to Provide $2.5 Million Bridge Facility to Haemacure

VANCOUVER, June 3 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP), a specialty pharmaceutical and medical device company, announced today the completion of a collaboration transaction with Haemacure Corporation (TSX:HAE), a specialty bio-therapeutics company, relating to certain of Haemacure's proprietary fibrin and thrombin technologies, both of which are currently in development.

As part of this collaboration, Angiotech has agreed to provide to Haemacure a senior secured bridge financing facility in the amount of US$2.5 million, with the option for Angiotech to invest an additional US$1 million in the facility.

"Our new collaboration with Haemacure provides Angiotech with access to critically important technology for certain of our surgical product candidates currently in preclinical development," said Dr. William Hunter, President and CEO of Angiotech. "We believe we have assembled the majority of the key components necessary to deliver on the next generation of innovations, adding to our proprietary Quill SRS franchise for our surgical business, and we will provide additional details as we prepare certain of these product candidates for the clinical development and regulatory approval process."

    The collaboration will consist principally of the following three
    agreements:

    -  Fibrin Sealant Distribution Agreement. The parties have entered into a
       Distribution Agreement whereby Angiotech is granted non-exclusive,
       world-wide distribution rights to Haemacure's fibrin sealant product
       candidate in selected surgical indications. The distribution agreement
       has a term on a country-by-country and product-by-product basis of
       10 years from the date Haemacure receives Unit
'/>"/>
SOURCE  Angiotech Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 

Related biology technology :

1. Angiotech Pharmaceuticals announces FDA approval of next-generation TAXUS(R) Liberte(R) Atom(TM) Stent system
2. Angiotechs corporate partner, Boston Scientific, announces launch of third-generation TAXUS(R) Element(TM) Stent
3. Angiotech launches e-commerce website that allows customers to order Quill(TM) SRS product line
4. Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009
5. Angiotech announces date of annual general meeting of shareholders
6. Angiotech Pharmaceuticals, Inc. Announces Conference Call And Webcast
7. Angiotech Pharmaceuticals, Inc. announces License Agreement with Baxter International Inc.
8. Angiotech announces positive results from Bio-Seal(TM) clinical study
9. Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008
10. Angiotech Pharmaceuticals, Inc. announces new Senior Secured Term Loan and Credit Facilities
11. Angiotech Pharmaceuticals announces time change of conference call and webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... 16 /PRNewswire/ -- Capitalizing ... sciences industry and an active venture capital market, ... State Teachers Retirement Fund, Indiana University, Purdue University, ... Foundation, and Credit Suisse today announced the establishment ... capital fund of funds. ,, Organized through BioCrossroads, ...
(Date:12/16/2009)... pursuant to Special Protocol Assessment with the ... Dec. 16 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. ... "Company"), a global biopharmaceutical company focused on ... initiation, by its partner Keryx Biopharmaceuticals Inc. ... registration clinical trial for perifosine (KRX-0401), the ...
(Date:12/16/2009)... its 23rd Annual Technical Conference & Exhibition on March 22-25, 2010 ... impact the separation society and reach out to even more experts ... AFS Annual Technical Conference will be co-located with the 2010 AIChE ... ... December 16, 2009 -- The American Filtration and Separations Society will ...
(Date:12/15/2009)... Sky One,Medical, Inc. ("China Sky One Medical" or ... integrated pharmaceutical company developing and producing,over-the-counter drugs in ... the Company has 30 medicines that will be ... Medical Insurance, Industrial Injury Insurance,and Maternity Insurance Medicine ... medicines treat a variety of common ailments and ...
Breaking Biology Technology:Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 2Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 3Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 4Indiana Industry, University and Community Leaders Capitalize on Next Generation of State's Life Sciences Growth 5AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 2AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 3AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 4AEterna Zentaris Partner, Keryx, Initiates Phase 3 Registration Trial with Perifosine (KRX-0401) for the Treatment of Patients with Advanced Multiple Myeloma 5American Filtration and Separations Society to Hold 23nd Annual Technical Conference 2American Filtration and Separations Society to Hold 23nd Annual Technical Conference 3American Filtration and Separations Society to Hold 23nd Annual Technical Conference 4China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 2China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 3
... Inc., of Madison has been licensed to sell ... labeling agents, GenTel announced on Tuesday. , ,GenTel will ... of Kreatech Biotechnology BV of Amsterdam, under ... kits are validated for use on GenTel's PATH protein ...
... Madison, Wis. -- A report is due this ... whether and how to proceed with an IT project that ... working to implement it over a five-year period. The project ... of good project management. , ,The Appointments, Payroll and Benefits ...
... Alfalight, Inc., a manufacturer of diode lasers for ... $7 million in expansion funding, the company reported ... by GF Private Equity Group, LLC and included ... Those include ARCH Venture Partners, Advanced Technology Ventures, ...
Other Biology Technology:UW working to salvage multi-million HR software project 2UW working to salvage multi-million HR software project 3UW working to salvage multi-million HR software project 4UW working to salvage multi-million HR software project 5Alfalight receives $7 million in expansion funding 2
(Date:12/17/2009)... developed a novel animal model showing that four commonly ... cells, and that the condition could be partially reversed ... online in the journal Cancer Investigation , the ... the legions of cancer survivors who experience a frustrating ... chemo-brain. , "It is not yet clear ...
(Date:12/17/2009)... YORK, Dec. 17, 2009 The Juvenile Diabetes Research ... research worldwide, said today that it will begin working ... and Technology, and its affiliates, to speed the development ... and function of insulin-producing cells in people who have ... at academic centers around the world that could eventually ...
(Date:12/17/2009)... -- Companies and communities trying to restore vegetation on ... to stimulate growth according to new research published in ... Research . , Not all plants benefit from the ... Stphane Boudreau, a Professor of Ecology at Universit Laval, ... of native plants in the northern village of Whapmagoostui ...
Breaking Biology News(10 mins):UR study reveals chemo's toxicity to brain, possible treatment 2UR study reveals chemo's toxicity to brain, possible treatment 3JDRF announces diabetes research program with Johnson & Johnson 2Fertilizer use not always helpful in revegetation efforts 2Taking dex can improve high altitude exercise capacity in certain climbers 54225 1Taking dex can improve high altitude exercise capacity in certain climbers 54225 2Taking dex can improve high altitude exercise capacity in certain climbers 54225 3Health Insurance Provider Sites Attract Fewer U S Visitors as Unemployment Increases 54224 1Health Insurance Provider Sites Attract Fewer U S Visitors as Unemployment Increases 54224 2Health Insurance Provider Sites Attract Fewer U S Visitors as Unemployment Increases 54224 3World Stem Cell Summit to Be Held in Baltimore 13504 1World Stem Cell Summit to Be Held in Baltimore 13504 2
... It is commonly thought that animals can be arranged ... Naturae—with humans inevitably at the top, followed by our ... fish and other slimy creatures. Over the past decade, ... intelligence and great social complexity in other animals. For ...
... to fight viruses is also involved in keeping cancer cells ... , The anti-viral molecule, called TBK-1, was found to be ... point to a treatment for fighting cancer, the researchers report ... the surprise that this mechanism is involved in cancer cell ...
... transform into a new life, or into new cells that ... the mechanics - in how a single cell can transform ... week in the Proceedings of the National Academy of ... egg. The identification opens the way to understanding these genes' ...
Other Biology News:Fishy cooperation 2Natural anti-viral enzyme helps keep cancer cells alive, researchers find 2Scientists crack genetic secrets of human egg 2
Request Info...
... a clone of the human Topoisomerase II gene. ... the topological state of nucleic acids by passing ... which generates a separate DNA helix (1,2) . ... mechanism, the enzyme can relax negatively or positively ...
Request Info...
... - Neurosphere is a system designed for ... neurospheres in a serum free environment. The kit ... which has been optimized for neural stem cell ... Genes & Development 10 :3129). Two growth ...
Biology Products: